FDA Finalizes Controversial Policies On Pill Shapes, Sizes
The U.S. Food and Drug Administration on Thursday finalized guidance on appropriate shapes and sizes for generic drugs, largely sticking to policies that generated striking controversy when originally proposed....To view the full article, register now.
Already a subscriber? Click here to view full article